Piper Sandler analyst Patrick Moley raised the firm’s price target on CME Group (CME) to $329 from $313 and keeps an Overweight rating on the shares. Heading into Q1 earnings, the firm expects management teams to strike a positive tone on the outlook for trading volumes, especially in futures as the Iran War continues to impact global energy and commodities markets. Piper is somewhat cautious on the tough year-over-year comparisons facing exchanges in Q2, but a continuation of the Iran War is a strong counter.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- CME Group to launch Eris SOFR Swap options on June 16
- CME Group price target lowered to $343 from $344 at Barclays
- Crypto Currents: Potential buyers reportedly looking at Gemini assets
- CME Group price target raised to $362 from $340 at Morgan Stanley
- CME Group price target raised to $340 from $328 at TD Cowen